Cite
Effectiveness of palonosetron for preventing delayed chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy in patients with gastrointestinal cancer.
MLA
Murakami, Michiyasu, et al. “Effectiveness of Palonosetron for Preventing Delayed Chemotherapy-Induced Nausea and Vomiting Following Moderately Emetogenic Chemotherapy in Patients with Gastrointestinal Cancer.” Supportive Care in Cancer, vol. 22, no. 4, Apr. 2014, pp. 905–09. EBSCOhost, https://doi.org/10.1007/s00520-013-2046-6.
APA
Murakami, M., Hashimoto, H., Yamaguchi, K., Yamaguchi, I., Senba, S., & Siraishi, T. (2014). Effectiveness of palonosetron for preventing delayed chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy in patients with gastrointestinal cancer. Supportive Care in Cancer, 22(4), 905–909. https://doi.org/10.1007/s00520-013-2046-6
Chicago
Murakami, Michiyasu, Hiroki Hashimoto, Kyohei Yamaguchi, Ikuko Yamaguchi, Shozo Senba, and Takeshi Siraishi. 2014. “Effectiveness of Palonosetron for Preventing Delayed Chemotherapy-Induced Nausea and Vomiting Following Moderately Emetogenic Chemotherapy in Patients with Gastrointestinal Cancer.” Supportive Care in Cancer 22 (4): 905–9. doi:10.1007/s00520-013-2046-6.